RNA, U1 small nuclear 138, pseudogeneGenealiases: []
Q-omics provides the consensus-scored RNU1-138P profile across patient tissues and cancer cell-line models. RNU1-138P expression is associated with patient survival in 18 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, RNU1-138P is differentially expressed in 10, with the highest sampling consensus in HNSC. Additionally, RNU1-138P RNA expression shows 8,541 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight HNSC, and ESCA as cancer lineages where RNU1-138P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNU1-138P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNU1-138P survival associations across molecular data types. RNU1-138P RNA expression shows survival associations in the most cancer types (18). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNU1-138P RNA expression–survival associations across cancer types. High RNU1-138P expression shows unfavorable associations in HNSC, BLCA, KICH, MESO, TGCT and LGG. The HNSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify HNSC as the clearest survival context for RNU1-138P RNA expression.
This table summarizes RNU1-138P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for RNU1-138P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNU1-138P shows higher tumor expression in HNSC, THCA, KIRP, LUSC, STAD and KIRC. The HNSC box plot shows higher RNU1-138P RNA expression in tumor versus normal tissue (log2 FC = +1.471, t-test p < 0.001).
This table shows molecular features associated with RNU1-138P in patient tissues and cancer cell lines. In patient samples, RNU1-138P shows the broadest associations at the RNA and protein expression levels, with ESCA recurring as the lineage with the largest associated feature set.
